Dr. Yasmine Abouleila completed her PhD in Biomedical and Health Sciences at Hiroshima University, Japan, where she focused on identifying new diagnostic biomarkers for early cancer detection through circulating tumor cells. Since joining the oncology department at HUB Organoids in 2022, she has been responsible for leading and designing several cancer research and immuno-oncology projects.